InvestorsHub Logo
Followers 33
Posts 1622
Boards Moderated 0
Alias Born 10/06/2015

Re: misiu143 post# 171110

Sunday, 06/20/2021 12:09:19 AM

Sunday, June 20, 2021 12:09:19 AM

Post# of 233488
Long haulers' and vaccine response, may be surprisingly similar. Of course with long haulers' you've at some point contracted Covid-19.

The vaccine effect doesn't rely on the covid being contracted, it's (if Kirsch is correct) involves vestiges of covid (to stimulate the production of antigens) of the virus in response to the vaccine's introduction.

It appears both can generate long term effects and both (an assumption) are largely treatable with Leronlimab.

******

Long haulers' = (Number contracting Covid-19) x (a factor of 10-30%) = BIG target population

******

Vaccine vestige reactions (which, again if Kirsch is accurate) could be immediate or appear at a "later date")

(Total number world-wide vaccinated with RNA vaccines) x (an unknown factor) = probably a HUGE market for leronlimab.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News